22 June 2008

Cure leukaemia with maths

It seems maths will lend its hand to medicine to cure patients suffering from chronic myelogenous leukaemia with the help of an optimally timed cancer vaccine. The timing here is said to determined based on their own immune response. The success of the whole process lies in creating a mathematical model, which envisages that anti-leukaemia immune response in CML patients can be simulated to cure the disease for those who chomp through the drug imatinib. In the course of combining the novel biological data and mathematical model rules for designing adaptive treatments have been found.

No comments: